IL21R and hepatocellular carcinoma: (iii) By using two different in vivo mouse models of MASH-driven HCC, the STAM model and the WD&High sugar solution&CCl4 model, we revealed that ablation of IL-21R obstructed MASH-driven HCC by enhancing CTL activation with large number of mice (n = 86 in total).